Form 8-K - Current report:
SEC Accession No. 0001100682-26-000115
Filing Date
2026-08-05
Accepted
2026-08-05 07:15:21
Documents
13
Period of Report
2026-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crl-20260805.htm   iXBRL 8-K 25245
2 EX-99.1 crl2q26earningsrelease.htm EX-99.1 447745
6 image_0.jpg GRAPHIC 47478
  Complete submission text file 0001100682-26-000115.txt   687716

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crl-20260805.xsd EX-101.SCH 1780
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crl-20260805_lab.xml EX-101.LAB 21880
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crl-20260805_pre.xml EX-101.PRE 12511
16 EXTRACTED XBRL INSTANCE DOCUMENT crl-20260805_htm.xml XML 2729
Mailing Address 251 BALLARDVALE ST WILMINGTON MA 01887
Business Address 251 BALLARDVALE ST WILMINGTON MA 01887 781-222-6000
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (Filer) CIK: 0001100682 (see all company filings)

EIN.: 061397316 | Fiscal Year End: 1227
Type: 8-K | Act: 34 | File No.: 001-15943 | Film No.: 261241334
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)